Financials data is unavailable for this security.
View more
Year on year Mukka Proteins Ltd grew revenues 17.22% from 11.77bn to 13.80bn while net income improved 58.94% from 440.75m to 700.53m.
| Gross margin | 18.77% |
|---|---|
| Net profit margin | 5.97% |
| Operating margin | 7.36% |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, Mukka Proteins Ltd increased its cash reserves by 255.73%, or 678.90m. Cash Flow from Financing totalled 2.66bn or 19.27% of revenues. In addition the company used 1.50bn for operations while cash used for investing totalled 475.94m.
| Cash flow per share | 2.97 |
|---|---|
| Price/Cash flow per share | 14.35 |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in INR
Year on year, growth in earnings per share excluding extraordinary items increased 58.94%. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
| EPS growth(5 years) | 37.43 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -- |
